Annual Total Long Term Liabilities
$34.70 M
-$121.14 M-77.73%
31 December 2023
Summary:
Sangamo Therapeutics annual total long term liabilities is currently $34.70 million, with the most recent change of -$121.14 million (-77.73%) on 31 December 2023. During the last 3 years, it has fallen by -$262.94 million (-88.34%). SGMO annual total long term liabilities is now -88.34% below its all-time high of $297.64 million, reached on 31 December 2020.SGMO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$28.97 M
-$1.35 M-4.46%
30 September 2024
Summary:
Sangamo Therapeutics quarterly total long term liabilities is currently $28.97 million, with the most recent change of -$1.35 million (-4.46%) on 30 September 2024. Over the past year, it has dropped by -$7.33 million (-20.18%). SGMO quarterly long term liabilities is now -90.93% below its all-time high of $319.27 million, reached on 30 September 2020.SGMO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -77.7% | -20.2% |
| 3 y3 years | -88.3% | -87.7% |
| 5 y5 years | -76.0% | -79.4% |
SGMO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -88.3% | at low | -87.7% | at low |
| 5 y | 5 years | -88.3% | at low | -90.9% | at low |
| alltime | all time | -88.3% | -90.9% |
Sangamo Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $28.97 M(-4.5%) |
| June 2024 | - | $30.32 M(-5.3%) |
| Mar 2024 | - | $32.02 M(-7.7%) |
| Dec 2023 | $34.70 M(-77.7%) | $34.70 M(-4.4%) |
| Sept 2023 | - | $36.29 M(-3.6%) |
| June 2023 | - | $37.64 M(-20.1%) |
| Mar 2023 | - | $47.12 M(-69.8%) |
| Dec 2022 | $155.84 M(-28.7%) | $155.84 M(-4.0%) |
| Sept 2022 | - | $162.40 M(-9.2%) |
| June 2022 | - | $178.86 M(-11.1%) |
| Mar 2022 | - | $201.26 M(-8.0%) |
| Dec 2021 | $218.69 M(-26.5%) | $218.69 M(-6.7%) |
| Sept 2021 | - | $234.48 M(-7.3%) |
| June 2021 | - | $252.96 M(-8.0%) |
| Mar 2021 | - | $274.84 M(-7.7%) |
| Dec 2020 | $297.64 M(+120.6%) | $297.64 M(-6.8%) |
| Sept 2020 | - | $319.27 M(+10.3%) |
| June 2020 | - | $289.51 M(+126.5%) |
| Mar 2020 | - | $127.80 M(-5.3%) |
| Dec 2019 | $134.91 M(-6.7%) | $134.91 M(-3.9%) |
| Sept 2019 | - | $140.34 M(-3.7%) |
| June 2019 | - | $145.69 M(+19.0%) |
| Mar 2019 | - | $122.42 M(-15.4%) |
| Dec 2018 | $144.63 M(+167.9%) | $144.63 M(-5.2%) |
| Sept 2018 | - | $152.57 M(-6.9%) |
| June 2018 | - | $163.91 M(+231.7%) |
| Mar 2018 | - | $49.41 M(-8.5%) |
| Dec 2017 | $53.98 M(+542.3%) | $53.98 M(+34.3%) |
| Sept 2017 | - | $40.20 M(-15.0%) |
| June 2017 | - | $47.30 M(+486.6%) |
| Mar 2017 | - | $8.06 M(-4.1%) |
| Dec 2016 | $8.40 M(+78.9%) | $8.40 M(+15.5%) |
| Sept 2016 | - | $7.27 M(+13.2%) |
| June 2016 | - | $6.42 M(-14.9%) |
| Mar 2016 | - | $7.55 M(+60.6%) |
| Dec 2015 | $4.70 M(-70.1%) | $4.70 M(-31.2%) |
| Sept 2015 | - | $6.83 M(-23.7%) |
| June 2015 | - | $8.95 M(-19.0%) |
| Mar 2015 | - | $11.05 M(-29.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $15.70 M(+74.5%) | $15.70 M(-11.4%) |
| Sept 2014 | - | $17.71 M(-10.0%) |
| June 2014 | - | $19.68 M(-9.2%) |
| Mar 2014 | - | $21.67 M(+140.8%) |
| Dec 2013 | $9.00 M(+1.7%) | $9.00 M(+24.6%) |
| Sept 2013 | - | $7.22 M(-7.0%) |
| June 2013 | - | $7.76 M(-6.5%) |
| Mar 2013 | - | $8.30 M(-6.1%) |
| Dec 2012 | $8.85 M(>+9900.0%) | $8.85 M(-5.8%) |
| Sept 2012 | - | $9.39 M(-5.5%) |
| June 2012 | - | $9.93 M(-5.2%) |
| Mar 2012 | - | $10.47 M(>+9900.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2009 | - | $0.00(-100.0%) |
| June 2009 | - | $55.00 K(-85.7%) |
| Mar 2009 | - | $384.00 K(-53.3%) |
| Dec 2008 | $823.00 K(-60.8%) | $823.00 K(-28.6%) |
| Sept 2008 | - | $1.15 M(-58.9%) |
| June 2008 | - | $2.80 M(+64.7%) |
| Mar 2008 | - | $1.70 M(-18.9%) |
| Dec 2007 | $2.10 M(+11.8%) | $2.10 M(-15.3%) |
| Sept 2007 | - | $2.48 M(+239.5%) |
| June 2007 | - | $729.00 K(-58.3%) |
| Mar 2007 | - | $1.75 M(-6.7%) |
| Dec 2006 | $1.88 M(-57.1%) | $1.88 M(-25.0%) |
| Sept 2006 | - | $2.50 M(-20.0%) |
| June 2006 | - | $3.13 M(-16.7%) |
| Mar 2006 | - | $3.75 M(-14.3%) |
| Dec 2005 | $4.38 M(+1358.3%) | $4.38 M(+1267.2%) |
| Sept 2001 | - | $320.00 K(-97.5%) |
| Mar 2000 | - | $12.62 M |
| Dec 1999 | $300.00 K | - |
FAQ
- What is Sangamo Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual total long term liabilities year-on-year change?
- What is Sangamo Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly long term liabilities year-on-year change?
What is Sangamo Therapeutics annual total long term liabilities?
The current annual total long term liabilities of SGMO is $34.70 M
What is the all time high annual total long term liabilities for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual total long term liabilities is $297.64 M
What is Sangamo Therapeutics annual total long term liabilities year-on-year change?
Over the past year, SGMO annual total long term liabilities has changed by -$121.14 M (-77.73%)
What is Sangamo Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of SGMO is $28.97 M
What is the all time high quarterly long term liabilities for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly total long term liabilities is $319.27 M
What is Sangamo Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, SGMO quarterly total long term liabilities has changed by -$7.33 M (-20.18%)